[China Cord Blood Corporation Receives Notification of HONG KONG, China, April 6, 2017 - China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today a]
[China Cord Blood Corporation Receives Notification of HONG KONG, China, April 6, 2017 - China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today a]
[CHINA CORD BLOOD CORPORATION CONVERSION NOTICE Note Company Shares Reference is made to the Senior Convertible Note (the Date of Conversion: April 6, 2017 Aggregate Principal amount to be converted: USD65,000,000 Please confirm the following information: Conversion Price: USD2.838 Number of Shares]
[CHINA CORD BLOOD CORPORATION CONVERSION NOTICE Note Company Shares Reference is made to the Senior Convertible Note (the Date of Conversion: April 6, 2017 Aggregate Principal amount to be converted: USD65,000,000 Please confirm the following information: Conversion Price: USD2.838 Number of Shares]
[SCHEDULE 13G/A Amendment No. 12 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) March 30, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The ]
[SCHEDULE 13G/A Amendment No. 12 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) March 30, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The ]
[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]
[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 3Q17 Added 19,712 New Subscribers 3Q17 Revenue Up 18.6% YOY to RMB200.9 Million ($28.9 Million) 3Q17 Operating Income Reached RMB101.7 Million ($14.6 Million) Conference Call to be Held ]
[SCHEDULE 13G/A Amendment No. 11 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) ☐ Rule13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * C]
[SCHEDULE 13G/A Amendment No. 11 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) ☐ Rule13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * C]
